- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05912348
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
This clinical trial aims to learn about the alterations in insulin resistance and metabolic flexibility following a transition to an obesogenic lifestyle in fit young men and women. The main questions it aims to answer are:
- Does adding excess carbohydrates when transitioning to a sedentary lifestyle promote insulin resistance and impaired 24hr glucose regulation in healthy men and women?
- Does adding excess carbohydrates when transitioning to a sedentary lifestyle lower the body's ability to break down fats and carbohydrates in healthy men and women?
- Does the added physical activity blunt shifts in carbohydrate and fat oxidation in healthy men and women?
Study Overview
Status
Detailed Description
Excess adiposity remains a critical health issue in the United States. Obesity and severe obesity are projected to reach approximately 34% and 9% by 2030, respectively. However, recent 2021 NHANES data reveals that our obesity and severe obesity population has already surpassed these estimates reaching 41.9% and 9.2% by 2022, respectively. While early childhood obesity has a prevalence of about 22%, which can lead to obesity during adulthood, young adulthood (20-39 years old) is another critical time where young adults without obesity or severe obesity will accumulate excess adiposity as part of this transition into middle-aged adulthood (40-59 years). In particular, young adults often transition from higher levels of physical activity (i.e., sports participation in high school, increased walking to class on college campuses, increased free time for physical activity) to lower levels of physical activity (e.g., full-time employment) and limited time to prepare healthy meals. Although obesity models tend to be complex, with multiple contributors to the development of obesity, easily accessible and rapidly digestible carbohydrates with high glycemic indexes have contributed significantly to the rise in obesity and cardiometabolic diseases in the United States.
Previous animal models have demonstrated that high carbohydrate or high-fat diets and increased sedentary activity lead to excess adiposity and insulin resistance in animal models. Animal models help us to examine mechanistic contributors to obesity and adverse cardiometabolic risks. A recently developed obesogenic lifestyle model provides an excellent model for studying the transition to an obesogenic lifestyle in healthy young adults. The obesogenic lifestyle model uses an acute exposure to a sedentary lifestyle (~5,000 steps/day) and increased carbohydrate intake (~2 liters of soda/day) for a 10-day period. Using this obesogenic lifestyle model, researchers found that the acute obesogenic lifestyle model increased insulin resistance (measured by HOMA-IR) in both men and women, but only men had declines in vascular insulin sensitivity. The reduction in vascular sensitivity is considered an early precursor for the development of metabolic dysregulation and cardiovascular disease. Nonetheless, it remains unclear whether insulin resistance and vascular insulin sensitivity were due to a lack of physical activity or increased carbohydrate intake. Further, the model must be independently validated to confirm its ability to induce insulin resistance to create a sustainable model for repeated studies.
From a behavioral aspect, the designed obesogenic lifestyle model provides an opportunity to study increases in insulin resistance when individuals transition during young adulthood into a lifestyle that induces barriers to maintaining physical activity and impairs diet quality. Importantly, this young adult population remains underrepresented in the literature compared to studies on obese or physically inactive adults. Therefore, the model has ecological relevance. The model also provides an opportunity for earlier interventions to be developed to mitigate the harmful consequences that may be offset with simple interventions that promote physical activity. Therefore, the global hypothesis of this research study is that the obesogenic lifestyle model will be a suitable model for studying the early onset of insulin resistance as it will increase insulin resistance (HOMA-IR) and impair glucose regulation in recreationally active young men and women.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael Brian, PhD
- Phone Number: 603-714-8899
- Email: Michael.Brian@unh.edu
Study Locations
-
-
New Hampshire
-
Durham, New Hampshire, United States, 03824
- Recruiting
- University of New Hampshire Cardiometabolic Research Laboratory
-
Principal Investigator:
- Michael Brian, PhD
-
Contact:
- Michael Brian, PhD
- Phone Number: 603-862-1693
- Email: Michael.Brian@unh.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-30 years of age
- Recreationally active completing 75-150 minutes of moderate-to-vigorous intensity exercise (>2 days/week).
- Fair cardiorespiratory fitness levels (Men: VO2>38.4 ml/kg/min; Women: VO2>32.6 ml/kg/min).
Exclusion Criteria:
- Hypertension (resting or diagnosed)
- Impaired fasting blood glucose (>100mg/dL)
- Diagnosed cardiovascular disease
- Diagnosed diabetes
- Diagnosed cancer
- Diagnosed chronic kidney disease
- Diagnosed musculoskeletal disorders that prevents the individual from exercising on a bike.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Normal Activity Control
Maintains normal physical activity levels and exercise training
|
|
|
Experimental: Low Physical Activity and Added Carbohydrate Group
10-days of low physical activity (~5,000 steps/day) while consuming added sugar-sweetened beverages (~180 g/day).
|
Young men and women will transition into a low physically active lifestyle for 10 days and consume added sugar-sweetened beverages.
The intervention group will be compared to two control groups and one experimental group.
One of the control groups will undergo a low physical activity intervention.
|
|
Placebo Comparator: Low Physical Activity Control
10-days of sedentary activity (~5,000 steps/day).
|
Young men and women will transition into a low physically active lifestyle for 10 days.
|
|
Experimental: High Physical Activity and Added Carbohydrate Group
10-days of high physical activity (~11,000 steps/day) while consuming added sugar-sweetened beverages (~180 g/day).
|
Young men and women will transition into a high physically active lifestyle for 10 days and consume added sugar-sweetened beverages.
The intervention group will be compared to two control groups and one experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine if low physical activity alone contributes to insulin resistance in healthy, recreationally active young men and women compared to men and women that reduce their physical activity and consume added sugar-sweetened beverages.
Time Frame: 10 days
|
We will use HOMA-IR to measure changes in insulin resistance across the 4 study groups
|
10 days
|
|
To determine if the combined low physical activity and added carbohydrates impairs 24-hour glucose regulation compared the other study interventions.
Time Frame: 10 days
|
Compare 24-hour glucose regulation (mmol/L) measurements across the four study groups
|
10 days
|
|
To determine if fat oxidation is impaired when participants reduce their physical activity levels and consume added carbohydrates compared to the three interventions
Time Frame: 10 days
|
Compare the change in fat oxidation after the 10 day intervention
|
10 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael S Brian, PhD, University of New Hampshire
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UNH-12-FY2023_85-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Low Physical Activity and Added Carbohydrate Group
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
Centro di Riferimento per l'Epidemiologia e la...Azienda Sanitaria Locale Torino 1CompletedBreast Cancer | Colorectal Cancer | Lifestyle Risk Reduction | Weight Changes, BodyItaly
-
Rigshospitalet, DenmarkNovo Nordisk A/S; Augustinus FondenCompletedType 2 Diabetes Mellitus | Insulin Resistance | DyslipidemiaDenmark
-
Universidad de CórdobaUnknown
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Third Affiliated Hospital of Zhengzhou UniversityRecruitingObesity | Weight Loss | Male Fertility | IVF-ET | Artificial InseminationChina
-
University of Nove de JulhoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.UnknownQuality of Life | PainBrazil
-
The Netherlands Cancer InstituteDutch Cancer SocietyUnknownMenopausal Symptoms in Breast Cancer Patients With Treatment-Induced Complaints
-
Gunma PAZ CollegeKanazawa UniversityCompletedPhysical Activity | Hemiplegia | Motor ActivityJapan